JP2016515630A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515630A5
JP2016515630A5 JP2016506667A JP2016506667A JP2016515630A5 JP 2016515630 A5 JP2016515630 A5 JP 2016515630A5 JP 2016506667 A JP2016506667 A JP 2016506667A JP 2016506667 A JP2016506667 A JP 2016506667A JP 2016515630 A5 JP2016515630 A5 JP 2016515630A5
Authority
JP
Japan
Prior art keywords
cancer
group
cooet
coome
tetrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016506667A
Other languages
English (en)
Japanese (ja)
Other versions
JP6417392B2 (ja
JP2016515630A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/033063 external-priority patent/WO2014165815A2/en
Publication of JP2016515630A publication Critical patent/JP2016515630A/ja
Publication of JP2016515630A5 publication Critical patent/JP2016515630A5/ja
Application granted granted Critical
Publication of JP6417392B2 publication Critical patent/JP6417392B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016506667A 2013-04-04 2014-04-04 強力なアンドロゲン受容体ダウンレギュレーションおよび抗前立腺ガン活性を伴う非ステロイド化合物およびステロイド化合物 Active JP6417392B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361808345P 2013-04-04 2013-04-04
US61/808,345 2013-04-04
US201361808902P 2013-04-05 2013-04-05
US61/808,902 2013-04-05
PCT/US2014/033063 WO2014165815A2 (en) 2013-04-04 2014-04-04 Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity

Publications (3)

Publication Number Publication Date
JP2016515630A JP2016515630A (ja) 2016-05-30
JP2016515630A5 true JP2016515630A5 (cg-RX-API-DMAC10.html) 2017-03-30
JP6417392B2 JP6417392B2 (ja) 2018-11-07

Family

ID=51659362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016506667A Active JP6417392B2 (ja) 2013-04-04 2014-04-04 強力なアンドロゲン受容体ダウンレギュレーションおよび抗前立腺ガン活性を伴う非ステロイド化合物およびステロイド化合物

Country Status (6)

Country Link
US (2) US9694005B2 (cg-RX-API-DMAC10.html)
EP (2) EP2991644B1 (cg-RX-API-DMAC10.html)
JP (1) JP6417392B2 (cg-RX-API-DMAC10.html)
AU (1) AU2014247941C1 (cg-RX-API-DMAC10.html)
CA (2) CA2908577C (cg-RX-API-DMAC10.html)
WO (1) WO2014165815A2 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016054472A1 (en) * 2014-10-02 2016-04-07 University Of Maryland, Baltimore Methods of treating pancreatic cancer
WO2017201683A1 (en) 2016-05-25 2017-11-30 Merck Sharp & Dohme Corp. Substituted tetrahydroisoquinoline compounds useful as gpr120 agonists
WO2017223320A1 (en) * 2016-06-22 2017-12-28 University Of Maryland, Baltimore Method for production of novel galeterone analogs and uses thereof
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) * 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
CN106902112B (zh) * 2017-03-07 2019-06-04 中国医学科学院医药生物技术研究所 Imb-a6作为雄激素受体拮抗剂的应用
CN111943889B (zh) * 2020-07-24 2022-07-22 中国医学科学院医药生物技术研究所 一种双芳香基胺类化合物及其制备方法和应用
CN116444599B (zh) * 2022-01-07 2026-02-03 中国科学院上海药物研究所 甾体类化合物及制备方法和用途
WO2024064026A1 (en) * 2022-09-19 2024-03-28 Alterome Therapeutics, Inc. Akt1 modulators
JP2025532245A (ja) 2022-09-26 2025-09-29 アルテローム セラピューティクス, インコーポレイテッド Akt1調節因子
WO2024091899A1 (en) * 2022-10-25 2024-05-02 University Of Maryland, Baltimore Salts of galeterone and salts of next generation galeterone analogs, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA129379A (en) 1910-10-18 1910-11-22 John Clarence Bisland Hoe
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
DE10342503A1 (de) 2003-09-12 2005-04-14 Merck Patent Gmbh Benzyl-Benzimidazolylderivate
JP5130453B2 (ja) * 2005-03-02 2013-01-30 ユニバーシティ オブ メリーランド,ボルティモア 新規なc−17−ヘテロアリールステロイドcyp17阻害剤/抗アンドロゲン:合成、インビトロ生物活性、薬物動態および抗腫瘍活性
EP2254572B1 (en) 2008-02-07 2013-10-16 Massachusetts Eye & Ear Infirmary Compounds that enhance atoh-1 expression
US20100048524A1 (en) * 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
WO2009120565A2 (en) * 2008-03-25 2009-10-01 University Of Maryland, Baltimore Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
WO2010091299A2 (en) * 2009-02-05 2010-08-12 Tokai Pharmaceuticals Novel combination cancer therapies
EP2393827B1 (en) * 2009-02-05 2015-10-07 Tokai Pharmaceuticals, Inc. Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
JP2014523445A (ja) * 2011-07-18 2014-09-11 トーカイ ファーマシューティカルズ,インク. 前立腺癌を処置するための新規な組成物及び方法
CA2904170A1 (en) * 2013-03-14 2014-09-25 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof

Similar Documents

Publication Publication Date Title
MX2024009540A (es) Esteroides neuroactivos y composiciones de estos.
JP2013545812A5 (cg-RX-API-DMAC10.html)
MX2014015158A (es) Derivados de piridinona y piridazinona.
PH12021552362A1 (en) Estrogen receptor degrading protacs
JP2011057693A5 (cg-RX-API-DMAC10.html)
JP2018518537A5 (cg-RX-API-DMAC10.html)
JP2012507521A5 (cg-RX-API-DMAC10.html)
JP2011526924A5 (cg-RX-API-DMAC10.html)
IL292245B2 (en) Polymorphic forms of RAD1901–2HCL
EP2456781A2 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9 (10)-dien-11-acyloxyalkylenphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
JP2013543894A5 (cg-RX-API-DMAC10.html)
MX2024014845A (es) Esteroides neuroactivos no saturados 9(11) y sus metodos de uso
CA2376158A1 (en) Use of selective estrogen receptor modulators in the manufacture of medicaments for treating and/or suppressing weight gain
AU2014247941C1 (en) Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
WO2008000483A3 (en) Phenol derivatives for the treatment of respiratory diseases
JP2011505356A5 (cg-RX-API-DMAC10.html)
MX2010006108A (es) Inhibidores de estearoil-coa-desaturasa.
JP2016509601A5 (cg-RX-API-DMAC10.html)
MX2014014969A (es) Combinacion de un inhibidor de la 17-alfa-hidroxilasa (c17,20-liasa) y un inhibidor especifico de la pi-3k para tratar una enfermedad tumoral.
JP2017505785A5 (cg-RX-API-DMAC10.html)
JP2015520233A5 (cg-RX-API-DMAC10.html)
JP4607860B2 (ja) 腫瘍阻害作用を有する抗−アンドロゲン性ピロリジン
JP2012509265A5 (cg-RX-API-DMAC10.html)
CN104755455B (zh) 可用于治疗癌症的巨大戟醇衍生化合物
JP2014512355A5 (cg-RX-API-DMAC10.html)